| scholarly article | Q13442814 |
| P2093 | author name string | C Huang | |
| S Richardson | |||
| M Petric | |||
| Huang C | |||
| Bitzan M | |||
| Karmali MA | |||
| Richardson S | |||
| Petric M | |||
| M Bitzan | |||
| M A Karmali | |||
| B Boyd | |||
| Boyd B | |||
| P2860 | cites work | Abnormalities in the glycosphingolipid content of human Pk and p erythrocytes | Q28336208 |
| Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia | Q33351117 | ||
| Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome | Q33351371 | ||
| Experimental verocytotoxemia in rabbits | Q33353985 | ||
| THE HEMOLYTIC-UREMIC SYNDROME. | Q33354915 | ||
| Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome | Q33396788 | ||
| Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects | Q33397728 | ||
| Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes | Q33397981 | ||
| The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome | Q33398109 | ||
| Haematology of the haemolytic uraemic syndrome | Q33428929 | ||
| The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. | Q33445781 | ||
| Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy | Q33453223 | ||
| The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli | Q33457864 | ||
| Hemolytic-uremic syndrome. Current concepts and management | Q33484017 | ||
| Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns | Q33493714 | ||
| Endothelial heterogeneity in Shiga toxin receptors and responses. | Q33493734 | ||
| Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro | Q33493841 | ||
| The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study | Q33494653 | ||
| Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype | Q34256166 | ||
| Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine | Q36215407 | ||
| Infection by verocytotoxin-producing Escherichia coli | Q36634680 | ||
| Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit | Q36785336 | ||
| Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511 | Q36974749 | ||
| Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants | Q36977977 | ||
| Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies | Q36997934 | ||
| Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. | Q38349693 | ||
| Cloning and expression of the genes specifying Shiga-like toxin production in Escherichia coli H19. | Q39965419 | ||
| Modification of the glycolipid-binding specificity of vero cytotoxin by polymyxin B and other cyclic amphipathic peptides | Q40154302 | ||
| Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1 | Q40214420 | ||
| The P blood group system: recent progress in immunochemistry and genetics | Q40301694 | ||
| Verotoxins and their glycolipid receptors. | Q40844228 | ||
| Immunochemical study of the human blood group P1, P, and Pk glycosphingolipid antigens | Q41072254 | ||
| Quantitative analysis of plasma neutral glycosphingolipids by high performance liquid chromatography of their perbenzoyl derivatives | Q41262205 | ||
| Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues | Q41474149 | ||
| Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron | Q42859529 | ||
| Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs | Q42941754 | ||
| Serological differences between verocytotoxin 2 and shiga-like toxin II. | Q43558451 | ||
| Existence of glucosaminyl lactosyl ceramide (amino CTH-I) in human erythrocyte membranes as a possible precursor of blood group-active glycolipids | Q45814817 | ||
| Red-blood-cell fragmentation in microangiopathic haemolytic anaemia: in-vitro studies | Q51202471 | ||
| Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content | Q54683456 | ||
| Reproduction of Edema Disease of Swine with Purified Shiga-like Toxin-II Variant | Q54703471 | ||
| Verotoxin receptor glycolipid in human renal tissue. | Q54736253 | ||
| Verotoxin production among porcine strains of Escherichia coli and its association with oedema disease. | Q54758286 | ||
| Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. | Q54764104 | ||
| Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2) | Q57563891 | ||
| P blood group regulation of glycosphingolipid levels in human erythrocytes | Q66961488 | ||
| Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function | Q67913265 | ||
| Cloning and sequencing of a Shiga-like toxin II-related gene from Escherichia coli O157:H7 strain 7279 | Q68090249 | ||
| Genotypic variation in pathogenic Escherichia coli O157:H7 isolated from patients in Washington, 1984-1987 | Q69484514 | ||
| Globotetraosylceramide is recognized by the pig edema disease toxin | Q69517260 | ||
| CD antigens 1989 | Q69651426 | ||
| Immunologic therapy for hemolytic-uremic syndrome | Q69702798 | ||
| A simple method of reducing the fading of immunofluorescence during microscopy | Q70161232 | ||
| [Hemolytic-uremic syndrome of infancy: 27 clinical and anatomic observations] | Q72336760 | ||
| The haemolytic-uraemic syndrome | Q72378136 | ||
| IMPROVED PROCEDURE FOR THE EXTRACTION OF LIPIDS FROM HUMAN ERYTHROCYTES | Q78521300 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| human erythrocyte | Q111535219 | ||
| P304 | page(s) | 3337-3347 | |
| P577 | publication date | 1994-08-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro | |
| P478 | volume | 62 |
| Q35125841 | A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles |
| Q33427445 | A rapid and sensitive method to measure the functional activity of Shiga toxins in human serum |
| Q34922868 | Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cells |
| Q36899294 | Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum |
| Q37408432 | Bacteriophages as pathogens and immune modulators? |
| Q38519709 | Binding of shiga toxin 2e to porcine erythrocytes in vivo and in vitro |
| Q57889172 | Cholesterol modulates glycolipid conformation and receptor activity |
| Q40009489 | Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin. |
| Q42037896 | Culture-Dependent and Culture-Independent Methods in Evaluation of Emission of Enterobacteriaceae from Sewage to the Air and Surface Water. |
| Q44175475 | Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2. |
| Q46538413 | Effect of verocytotoxins (Shiga-like toxins) on human neutrophils in vitro |
| Q34004067 | Escherichia coli O157:H7 causes more-severe systemic disease in suckling piglets than in colostrum-deprived neonatal piglets |
| Q36845005 | Evaluation of major types of Shiga toxin 2E-producing Escherichia coli bacteria present in food, pigs, and the environment as potential pathogens for humans |
| Q38316435 | Evasion of killing by human antibody and complement through multiple variations in the surface oligosaccharide of Haemophilus influenzae. |
| Q38691126 | Histo-blood group glycans in the context of personalized medicine. |
| Q33375578 | Interactions of Shiga-like toxin with human peripheral blood monocytes |
| Q47127903 | Microvesicle Involvement in Shiga Toxin-Associated Infection |
| Q24550740 | Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections |
| Q54165055 | Photochemical labeling of human erythrocyte membranes with radioiodinatable azidosalicylic acid derivative of globoside |
| Q64992859 | Roles of Shiga Toxins in Immunopathology. |
| Q33503400 | Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid |
| Q33397541 | Shiga toxin pathogenesis: kidney complications and renal failure |
| Q33389321 | Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction |
| Q33402784 | Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies |
| Q38022246 | The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety? |
Search more.